Effect of intravenous zoledronic acid (ZA) on bone metastasis in patients with metastatic renal cell cancer (mRCC)

被引：0
|
作者：
Gruenwald, V. [1 ]
Wirth, M. [2 ]
Zantl, N. [3 ]
Schulze, M.
May, C. [4 ]
Ruebel, A. [4 ]
Tunn, U. [5 ]
机构：
[1] Hannover Med Sch, D-30623 Hannover, Germany
[2] Univ Klinikum Carl Gustav Carus Dresden, Dresden, Germany
[3] Klinikum Konstanz, Constance, Germany
[4] Novartis Pharma GmbH, Nurnberg, Germany
[5] Stadt Kliniken Offenbach, Offenbach, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [1] Incidence of osteonecrosis of the jaw (ONJ) in metastatic renal cell cancer patients (mRCC) treated with zoledronic acid (ZA)
    Gyergyay, Fruzsina
    Nagyivanyi, Krisztian
    Biro, Krisztina
    Kuronya, Zsofia
    Nemeth, Hajnalka
    Geczi, Lajos
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] The effect of zoledronic acid on bone metastasis in patients with metastatic renal cell cancer - a German prospective single-arm clinical trial
    Gruenwald, V.
    Stenzl, A.
    Strauss, A.
    Kindler, M.
    Miller, K.
    Ruebel, A.
    Albrecht, M.
    Tunn, U.
    EJC SUPPLEMENTS, 2009, 7 (02): : 435 - 435
  • [3] Effect of Acridine Orange and Zoledronic Acid on Bone Metastasis in Renal Cell Carcinoma
    Oya, Keita
    Tsuchie, Hiroyuki
    Nagasawa, Hiroyuki
    Hongo, Michio
    Kasukawa, Yuji
    Kudo, Daisuke
    Shoji, Ryo
    Kasama, Fumihito
    Kawaragi, Takashi
    Watanabe, Manabu
    Tominaga, Kenta
    Miyakoshi, Naohisa
    ANTICANCER RESEARCH, 2024, 44 (06) : 2487 - 2495
  • [4] THE ZOTECT STUDY: EFFECT OF INTRAVENOUS ZOLEDRONIC ACID ON BONE METABOLISM IN PATIENTS WITH METASTATIC BONE DISEASE IN BREAST CANCER AND PROSTATE CANCER
    Gschwend, J.
    Ziller, M.
    Kalder, M.
    Muth, M.
    Ruebel, A.
    Schmidt, K.
    Hadji, P.
    ANNALS OF ONCOLOGY, 2010, 21 : 117 - 118
  • [5] Zoledronic acid in breast cancer patients with bone metastasis
    Halim, I. Abdel
    El Ashry, M.
    El Sherbini, E.
    El Sadda, W.
    EJC SUPPLEMENTS, 2009, 7 (02): : 279 - 280
  • [6] Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancer
    Weinfurt, KP
    Anstrom, KJ
    Castel, LD
    Schulman, KA
    Saad, F
    ANNALS OF ONCOLOGY, 2006, 17 (06) : 986 - 989
  • [7] Safety of oral ibandronate and intravenous zoledronic acid in breast cancer patients with metastatic bone disease
    Body, JJ
    Lichinitser, MR
    Tjulandin, SA
    Coleman, RE
    Bergström, B
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S260 - S260
  • [8] The ZOTECT study: Effect of intravenous zoledronic acid on bone metabolism in patients with metastatic bone disease in prostate cancer (PC) and breast cancer (BC).
    Hadji, P.
    Ziller, M.
    Maurer, T.
    Muth, M.
    Ruebel, A.
    May, C.
    Birkholz, K.
    Gschwend, J. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] THE EXAMINATION OF THE EFFECT OF THE ZOLEDRONIC ACID FOR THE BONE METASTASIS OF BREAST CANCER
    Fujisawa, T.
    Hirakata, T.
    Miyamoto, T.
    Yanagita, Y.
    Yamane, M.
    Myo, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 163 - 163
  • [10] Effect of acridine orange and zoledronic acid on renal cell carcinoma local bone metastasis model
    Oya, Keita
    Tsuchie, Hiroyuki
    Nagasawa, Hiroyuki
    Hongo, Michio
    Kasukawa, Yuji
    Kudo, Daisuke
    Shoji, Ryo
    Kasama, Fumihito
    Okamoto, Kento
    Kawaragi, Tsuyoshi
    Watanabe, Manabu
    Tominaga, Kenta
    Miyakoshi, Naohisa
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 279 - 279
12345